1317234 B.C. Ltd. reverse takeover of RTRS Technologies Inc., raising at least $6.85M
September 11, 2026
1317234 B.C. Ltd. (“234 B.C.”) and RTRS Technologies Inc. (“RTRS”) entered into a definitive merger agreement to execute a reverse takeover that will list the combined business on the TSX Venture Exchange. Concurrently, the transaction includes a best-efforts private placement raising gross proceeds of not less than $6.85 million via subscription receipts, with Haywood Securities acting as lead agent and sole bookrunner.
- Buyers
- 1317234 B.C. Ltd., Haywood Securities Inc.
- Targets
- RTRS Technologies Inc.
- Platforms
- 1317234 B.C. Ltd.
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bradbury Capital Holdings completes business combination with Technology & Telecommunication Acquisition Corporation (TETE)
October 6, 2026
Payments & Fintech
Bradbury Capital Holdings completed its previously announced business combination with Technology & Telecommunication Acquisition Corporation (TETE), changing its name to Bradbury Capital Inc. Concurrently, the company completed a $5 million PIPE investment and will begin trading on Nasdaq under the ticker BBCI (and BBCI W for warrants) on October 7, 2026.
-
Vienna Parent / BCforward Acquire TSR, Inc.
July 3, 2024
Staffing & HR
Vienna Parent Corporation (an SPV formed by Justin Christian) and its purchaser Vienna Acquisition Corporation completed a cash tender offer to acquire all outstanding shares of TSR, Inc. (NASDAQ:TSRI), taking the IT staffing firm private for $13.40 per share. The acquisition, by an affiliate of BCforward, expands BCforward’s workforce management and IT staffing capabilities and will result in TSR ceasing trading on the Nasdaq.
-
Medix Biochemica Group Acquires Bioresource Technology (BRT)
June 21, 2022
Biotechnology
Medix Biochemica has acquired a 100% stake in US-based Bioresource Technology (BRT) to expand its base matrix capabilities and strengthen its presence in the United States. BRT will be integrated into Medix Biochemica’s IVD Biomaterials Business Unit (St. Louis) while operations continue in Weston, Florida, and BRT leadership will serve as strategic advisors.
-
Bristol Myers Squibb Acquires Turning Point Therapeutics
June 3, 2022
Healthcare Services
Bristol Myers Squibb will acquire Turning Point Therapeutics in a $4.1 billion, all-cash transaction at $76.00 per share under a definitive merger agreement. The deal was originally expected to close in Q3 2022, and the acquisition was completed in August 2022.
-
Mountain Crest Acquisition Corp II Completes Business Combination with Better Therapeutics
October 29, 2021
Healthcare Services
Mountain Crest Acquisition Corp II completed a business combination with Better Therapeutics, taking the prescription digital therapeutics company public on Nasdaq under the ticker BTTX. The transaction generated approximately $70 million in gross proceeds (including a PIPE led by Farallon Capital Management, RS Investments, Sectoral Asset Management and Monashee Investment Management) and included a contingent credit facility from Hercules Capital to fund clinical development and regulatory efforts for Better Therapeutics' lead product, BT-001.
-
Montagu Private Equity Acquires Majority Stake in ITRS Group from TA Associates
January 19, 2021
Software
Montagu Private Equity has agreed to acquire a majority position in ITRS Group from TA Associates, which will remain a minority shareholder alongside Montagu and ITRS management. ITRS, a London-headquartered provider of real-time monitoring and analytics software with more than 3,000 clients globally, will partner with Montagu to accelerate growth and expand its product and market footprint.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.